<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03271840</url>
  </required_header>
  <id_info>
    <org_study_id>pro00074669</org_study_id>
    <nct_id>NCT03271840</nct_id>
  </id_info>
  <brief_title>Registry for Primary Ciliary Dyskinesia</brief_title>
  <official_title>Registry for Primary Ciliary Dyskinesia: : Systematic Data Collection on Incidence, Clinical Presentation, Treatment and Course of the Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alberta</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary Ciliary Dyskinesia (PCD) is a rare disease, which means that any single PCD center&#xD;
      has experience with a limited number of patients. PCD Registry is the collection of data&#xD;
      about PCD from many centers and countries who treat children with PCD. Collecting data about&#xD;
      PCD increase the knowledge on PCD, better describe the course of the disease, and help to&#xD;
      better understand the progression of the disease and be used to develop new treatments.&#xD;
&#xD;
      In the PCD registry of Alberta, important information about PCD such as time of diagnosis,&#xD;
      symptoms, and tests which led to the diagnosis, state of health at diagnosis, the progression&#xD;
      of lung function, the occurrence of severe infections, tests and treatments data will be&#xD;
      collected from the patients' medical records.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In order to better characterize the clinical course, and improve the diagnosis and treatment&#xD;
      of PCD, the investigators propose to establish a provincial PCD registry in Alberta. This&#xD;
      registry will be securely linked to the currently existing International Registry for PCD and&#xD;
      will allow more researchers to use the information to do research on PCD.&#xD;
&#xD;
      The investigators will collect demographic data: current age, sex, age, diagnostic findings&#xD;
      and symptoms at diagnosis; in addition, clinical data about PCD which are recorded during the&#xD;
      past and future clinical visits and encounters (e.g. lung function, weight, height,&#xD;
      infections, treatments, and complications) will also be collected.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 26, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2030</completion_date>
  <primary_completion_date type="Anticipated">January 2030</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Age of diagnosis</measure>
    <time_frame>2017-2030</time_frame>
    <description>Years</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lung Function</measure>
    <time_frame>2017-2030</time_frame>
    <description>% predicted for age</description>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Primary Ciliary Dyskinesia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with PCD&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of PCD&#xD;
&#xD;
          -  Abnormal findings in at least two of the following tests:&#xD;
&#xD;
        High-frequency video microscopic finding, transmission electron microscopy finding,&#xD;
        immunofluorescence finding, low nasal NO concentration/production, demonstration of&#xD;
        biallelic disease-causing mutations by genotyping.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        â€¢ Failure or unwillingness to give written informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Israel Amirav, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alberta</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Israel Amirav, M.D</last_name>
    <phone>7808840296</phone>
    <email>amirav@ualberta.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alberta</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G2C6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Israel Amirav</last_name>
      <phone>7808840296</phone>
      <email>amirav@ualberta.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>August 26, 2017</study_first_submitted>
  <study_first_submitted_qc>August 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2017</study_first_posted>
  <last_update_submitted>November 3, 2020</last_update_submitted>
  <last_update_submitted_qc>November 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ciliary Motility Disorders</mesh_term>
    <mesh_term>Dyskinesias</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

